Nuvigil Jet Lag Indication Could Triple Potential Patients
This article was originally published in The Pink Sheet Daily
Executive Summary
Cephalon's sNDA, if approved, will create the marketing challenge of reaching a population of acute, not chronic, suffers.
You may also be interested in...
FDA Pushes Back Action Date For Nuvigil Label Expansion Due To New Data
Cephalon, which has positioned Nuvigil to replace Provigil as the latter sleep drugs faces patent expiry, hopes to add treatment of jet lag to label.
FDA Pushes Back Action Date For Nuvigil Label Expansion Due To New Data
Cephalon, which has positioned Nuvigil to replace Provigil as the latter sleep drugs faces patent expiry, hopes to add treatment of jet lag to label.
An Easy Landing? Cephalon Scores Priority Review For Nuvigil In Jet Lag Disorder
Some, however, remain skeptical of the medicine's potential after the Provigil patent expires.